IMC-Chicago, LLC - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,361,662
-6.8%
41,300
-5.7%
0.01%
-7.1%
Q2 2023$15,413,658
+3.6%
43,800
-7.2%
0.01%
-17.6%
Q1 2023$14,871,304
+28.4%
47,200
+17.7%
0.02%
-5.6%
Q4 2022$11,580,078
+77.7%
40,100
+78.2%
0.02%
+125.0%
Q3 2022$6,515,000
+113.4%
22,500
+92.3%
0.01%
+166.7%
Q1 2022$3,053,000
+29.9%
11,700
+9.3%
0.00%
+50.0%
Q4 2021$2,350,000
-2.5%
10,700
+4.9%
0.00%
-33.3%
Q4 2020$2,411,000
+196.9%
10,200
+108.2%
0.00%0.0%
Q4 2018$812,0004,9000.00%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 121,500$22,039,0000.02%
SG Americas Securities, LLC 100,000$3,764,0000.02%
SIMPLEX TRADING, LLC 61,900$12,516,0000.01%
Maven Securities LTD 1,300$236,0000.01%
JPMORGAN CHASE & CO 39,100$7,092,0000.00%
Allianz Asset Management GmbH 7,200$1,306,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders